Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 5, 2006, Pages 975-978

  Celenza, Giuseppe ^a   Pellegrini, Cristina ^a   Caccamo, Marisa ^a   Segatore, Bernardetta ^a   Amicosante, Gianfranco ^a   Perilli, Mariagrazia ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

CTX M 2; CTX M 43; PER 2; South America

Indexed keywords

AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE CTX M 43; BETA LACTAMASE PER 2; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; PIPERACILLIN; TAZOBACTAM; UNCLASSIFIED DRUG;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM COLONY; BACTERIUM ISOLATE; BOLIVIA; DNA SEQUENCE; DOT HYBRIDIZATION; ENTEROBACTERIACEAE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE IDENTIFICATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS;

ACINETOBACTER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; BETA-LACTAMASES; BOLIVIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; GENES, BACTERIAL; HOSPITALS, GENERAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PSEUDOMONAS AERUGINOSA;

EID: 33645829592     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl055     Document Type: Article

References (9)

1. Bell JM, Turnidge JD, Gales AC et al. Prevalence of extended spectrum β-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: Regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn Microbiol Infect Dis 2002; 42: 193-8.
2. Winokur PL, Canton R, Casellas JM et al. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 2001; 32 Suppl 2: 94-103.
3. Quinteros M, Radice M, Gardella N et al. Extended-spectrum β-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, public hospitals. Antimicrob Agents Chemother 2003; 47: 2864-7.
4. Pallecchi L, Malossi M, Mantella A et al. Detection of CTX-M-type β-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. Antimicrob Agents Chemother 2004; 48: 4556-61.
5. Tzouvelekis LS, Tzelepi E, Tassios PT et al. CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 2000; 14: 137-42.
6. PER-2, which encodes an extended-spectrum class A β-lactamase. Antimicrob Agents Chemother 1996; 40: 616-20.
7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Document M100-S15 CLSI, Wayne, PA, USA, 2005.
8. Perilli M, Dell'Amico E, Segatore B et al. Molecular characterization of extended-spectrum β-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J Clin Microbiol 2002; 40: 611-4.
9. Deshpande LM, Fritsche TR, Jones RN. Molecular epidemiology of selected multidrug-resistant bacteria: A global report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 2004; 49: 231-6.